Other languages Telesis Bio, Inc.

Equities

TBIO

US1920032000

Market Closed - Nasdaq Other stock markets 15:59:50 2024-06-26 EDT			5-day change	1st Jan Change
3.87 ^USD	+4.59%		+2.11%	-46.12%

05-09	Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M	MT
05-09	Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09
Telesis Bio, Inc. Announces Appointment of Eric Esser to the Board of Directors	04-18
Telesis Bio Inc. Announces Strategic Focus on Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform and BioXp mRNA Solutions	04-18
Telesis Bio, Inc. Announces Chief Executive Officer Changes	04-18
Telesis Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-28
Telesis Bio, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	02-26
Telesis Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13
Telesis Bio, Inc. Provides Earnings Guidance for 2023	11-13
Telesis Bio, Inc. Announces Default of 2022 Term Loan Agreement	11-09
Telesis Bio, Inc. Announces Board Changes	23-09-22
Telesis Bio Names William Kullback as CFO	23-08-29
Telesis Bio Downgraded by KeyBanc Over 'Tepid' Biopharma Spending, 'Significant Dilution'	23-08-11
Telesis Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Top Premarket Gainers	23-06-12
Telesis Bio, Inc. Appoints Paul Meister as Director	23-06-09
Telesis Bio Secures $28 Million Preferred Equity Financing	23-06-01
Telesis Bio Makes First Commercial Shipment of BioXp Select DNA Cloning Kit; Shares Rise	23-05-22
Telesis Bio Makes First Commercial Shipment of BioXp NGS Library Prep Kit	23-05-18
Wall Street Set to Open Higher; Import Prices Rebound More Than Expected	23-05-12
Telesis Bio Q1 Loss Narrows While Sales Increase	23-05-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Telesis Bio, Inc.

Equities

TBIO

US1920032000

Other languages

Filters